AI technology to assess cardiovascular risk through retinal images receives CE, UKCA marks
Click Here to Manage Email Alerts
Key takeaways:
- The European and UK markets will have access to the CLAiR technology from Toku.
- CLAiR assesses cardiovascular disease risk using retinal images.
Toku has obtained CE and UKCA marks for its CLAiR technology to assess cardiovascular disease risk using retinal images, according to a press release.
CLAiR uses artificial intelligence to analyze changes in the retina and its vasculature to detect elevated cardiovascular risk.
Image: Adobe Stock
The technology integrates with existing retinal cameras, provides real-time risk assessments during routine eye exams, and can be used in various settings to help identify adults with elevated cardiovascular risk, particularly those with no known history of cardiovascular disease.
“I believe that a retinal image can be considered the ‘fifth vital’ along with temperature, heart rate, respiration rate and blood pressure,” Ehsan Vaghefi, CEO of Toku, said in the release. “The CE and UKCA marks allow us to bring CLAiR to patients across multiple geographies. In my vision of the future, a retinal image analysis is an integral part of a comprehensive screening for major diseases such as cardiovascular or kidney disease.”
Read more about
Click Here to Manage Email Alerts